TGA Approval

APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 4.5mg capsule blister pack (160567)

ARTG ID

160567

ARTG Name

APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 4.5mg capsule blister pack

Sponsor

Arrotex Pharmaceuticals Pty Ltd

ARTG Date

July 27, 2010

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Arrotex Pharmaceuticals Pty Ltd.

Ingredient Name

rivastigmine hydrogen tartrate

Empowering clinical research with data-driven insights and AI-powered tools.

APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 4.5mg capsule blister pack (160567) - TGA 批准文号 | MedPath